StratDeck

Two stocks in Drug Manufacturers - General

Merck & Co. vs Pfizer: profit, growth, debt and price compared

Pfizer is stronger on 4 of 7 figures: profit margin, debt, price for its expected profit and dividend. Merck & Co. is stronger on 2: sales growth and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance

Save both stocks to your watchlist and revisit their latest fundamentals.

Merck & Co. and Pfizer side by side
Merck & Co.MRKPfizerPFE
Net margin3.6%Stronger: 6.3%
Revenue growth, past yearStronger: +4.68%−0.43%
Debt to equity119.9%Stronger: 71.0%
Forward P/E15.4×Stronger: 9.5×
Dividend yield2.47%Stronger: 6.13%
AnalystsBuy · 26Buy · 26
From its 200-day averageStronger: +6.4%+6.1%

Share price over the past year

  • Merck & Co.+42.9%
  • Pfizer+10.3%

18 Nov 202518 Nov 2026

Merck & Co. or Pfizer: which is stronger?

  • PFE

    Which is more profitable?

    Pfizer keeps more of each sale as profit: 6.3% against 3.6%.

  • MRK

    Which is growing its sales faster?

    Merck & Co. is growing its sales faster: +4.68% over the past year, against −0.43%.

  • PFE

    Which has borrowed less?

    Pfizer has borrowed less: its debt is 71.0% of what its shareholders own, against 119.9% for Merck & Co.

  • PFE

    Which costs less for the profit it is expected to make?

    Pfizer costs less for the profit it is expected to make: 9.5× its forward earnings, against 15.4×.

  • PFE

    Which pays more in dividends?

    Pfizer pays more back in dividends for what a share costs: 6.13% a year, against 2.47%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • MRK

    Which is in the stronger price trend?

    Merck & Co.'s price is in the stronger trend: 6.4% above its 200-day average, against 6.1% above.

What each company does

MRKMerck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide.

Reports results on 2 February 2027

PFEPfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Reports results on 2 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.